In this study, we found that, compared with the MCAO group, delayed treatment with kallikrein starting at all time points significantly increased vascular density at 14 days after ischemia in peri-infarction area, suggesting that delayed kallikrein treatment can promote angiogenesis of brain ischemia. This evidence concerns the gene KLK4 and infarction.